NSEDisclosure under SEBI Takeover RegulationsRelated Party23 Jun 2026
Nureca Limited
Disclosure under SEBI Takeover Regulations
Saurabh Goyal has submitted a disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for Nureca Limited. This regulatory filing pertains to an acquisition of shares by a person acting in concert with the promoters or acquirer, which is exempt from an open offer. The announcement is a compliance update regarding changes in shareholding, likely involving related parties.
NSEPress Release20 Jun 2026
Nureca Limited
Press Release
Nureca Limited announced a significant milestone for its "Dr Trust 360" platform, which has now crossed 2.4 million users. Alongside this user growth, the company has launched "Advanced AI Health Analytics" within the platform. This development highlights Nureca's expanding user base and its commitment to enhancing its health technology offerings with artificial intelligence. For investors, it indicates potential for increased engagement and a stronger competitive edge in the digital health sector.
NSEAgreements20 Jun 2026
Nureca Limited
Agreements
Nureca Limited has informed the exchanges about a Family Settlement Agreement (FSA) executed on June 17, 2026, which involves certain members of its Promoter/Promoter Group. The company explicitly stated that it is not a party to this FSA. Furthermore, Nureca Limited has not independently verified the contents of the agreement, making this disclosure based solely on information furnished by the promoter group. This suggests the agreement is an internal matter among the promoters, with no direct operational or financial involvement from the company itself.